Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: The SARICOR Randomized Clinical Trial

JULIAN CARLOS DE LA TORRE CISNEROS2026-01-292026-01-29202210.1128/aac.02107-212-s2.0-85124635833https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/34281Infectious DiseasesPharmacologyPharmacology (medical)Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: The SARICOR Randomized Clinical Trialresearch article